Overview:
Egypt for Aluminum, a public-sector metals company, reported net profit of 4.93 billion pounds for the three months ending September 2026, nearly double the 2.41 billion pounds earned in the same quarter of 2025. Sales rose 6.35 percent to 12.05 billion pounds. The company attributed gains to improved operational performance and market conditions in a sector that remains a cornerstone of Egypt's industrial export base.
Details:
Egypt for Aluminum, part of the state-owned metals holding company, achieved the profit surge despite a modest 6.35 percent increase in quarterly revenues, indicating improved cost management and margin expansion. The 104 percent year-on-year profit jump signals stronger pricing power or production efficiency gains in the aluminum market. The first quarter of the 2026-2027 fiscal year (July-September) marks the strongest performance for the company in recent periods.
Separately, Egypt Pharma—another public enterprise—posted 132.59 million pounds in net profit for the same quarter, down from 143.67 million pounds a year earlier. Pharma's sales contracted 13.1 percent to 566.12 million pounds, though the company maintained profitability. The divergence between aluminum's strength and pharma's contraction underscores sector-specific headwinds in domestic and export markets.
Outlook:
Investors are monitoring whether aluminum's profit momentum can sustain amid global commodity price volatility and whether pharma can stabilize revenues through operational adjustments or new product launches. Policy focus remains on leveraging public industrial companies to reduce import dependency and expand manufacturing exports.